Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

TRUL Insider Trading

Trulieve Cannabis Corp. | Medicinal Chemicals & Botanical Products

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Trulieve Cannabis Corp. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Medicinal Chemicals & Botanical Products sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-08-13 23:54 2024-11-21 May Richard S. Director BUY $6.05 1,610 $9,741 551,486 +0.3%
2025-08-14 00:01 2024-11-20 Thronson Susan Director BUY $6.30 3,968 $24,998 9,740 +68.7%
2024-12-14 00:13 2024-12-11 Getman Wes Officer - Chief Financial Officer BUY $4.91 9,500 $46,645 47,000 +25.3%
2024-11-22 02:28 2024-11-21 Healy Peter Director BUY $6.05 8,130 $49,187 30,625 +36.1%
2024-11-22 02:06 2024-11-21 May Richard S. Director BUY $6.05 1,160 $7,018 551,036 +0.2%
2024-11-22 01:48 2024-11-12 Collins Gina Officer - Chief Marketing Officer BUY $6.37 1,250 $7,963 103,931 +1.2%
2024-11-22 01:55 2024-11-20 Thronson Susan Director BUY $6.30 3,968 $24,998 26,463 +17.6%
2024-11-22 02:11 2024-11-21 MORREAU JANE C Director BUY $6.06 1,235 $7,484 23,730 +5.5%
2024-11-22 01:59 2024-11-19 MILLNER THOMAS L Director BUY $6.12 8,000 $48,960 30,495 +35.6%
2024-11-20 00:21 2024-11-15 Beshears Thad Director BUY $6.65 7,500 $49,875 2,444,995 +0.3%
2024-11-19 00:59 2024-11-15 Rivers Kim A. Director, Officer, 10% owner - Chairman and CEO BUY $6.65 7,400 $49,210 1,966,345 +0.4%
2024-11-15 02:13 2024-11-13 Powers Eric Officer - Chief Legal Officer BUY $6.10 1,000 $6,100 1,000 +100.0%
2024-11-15 02:06 2024-11-08 Jhala Nilyum Officer - Chief Technology Officer BUY $6.28 6,000 $37,670 6,000 +100.0%
2024-11-14 02:36 2024-11-08 Zhang Marie Officer - Chief Operating Officer BUY $7.19 21,300 $153,147 58,800 +56.8%
2024-11-14 02:24 2024-11-11 Landrum Kyle Officer - Chief Production Officer BUY $6.50 3,800 $24,698 134,618 +2.9%
2024-05-21 01:30 2024-05-16 Alvarez Giannella Director SELL $12.76 1,072 $13,678 44,732 -2.3%
2023-03-17 01:10 2023-03-15 Rivers Kim A. Director, Officer, 10% owner - Chairman and CEO BUY $6.08 4,110 $24,984 2,495,686 +0.2%
2022-05-26 03:31 2022-05-24 White Steven Matthew Officer - President BUY $14.32 7,000 $100,240 2,400,674 +0.3%
2022-05-26 03:30 2022-05-24 Rivers Kim A. Director, Officer, 10% owner - Chairman and CEO BUY $14.45 14,000 $202,300 2,497,917 +0.6%
2022-05-25 23:59 2022-05-24 Morey Timothy Officer - Chief Sales Officer BUY $14.29 700 $10,003 32,109 +2.2%
2022-05-25 23:57 2022-05-24 Landrum Kyle Officer - Chief Production Officer BUY $14.24 1,250 $17,800 32,659 +4.0%
2022-05-25 23:55 2022-05-24 Powers Eric Officer - GC and Corporate Secretary BUY $14.27 1,700 $24,259 33,109 +5.4%
2022-05-26 03:28 2022-05-24 D'Amico Alex Officer - Chief Financial Officer BUY $14.39 1,500 $21,585 85,587 +1.8%
2021-08-17 23:58 2021-08-16 Rivers Kim A. Director, Officer, 10% owner - President and CEO BUY $27.91 3,509 $97,926 81,429 +4.5%
2021-08-18 00:05 2021-08-17 D'Amico Alex Officer - Chief Financial Officer BUY $27.00 660 $17,820 2,820 +30.6%
2021-06-16 01:19 2021-06-15 Rivers Kim A. Director, Officer, 10% owner - President and CEO BUY $35.94 29,000 $1,042,150 77,920 +59.3%
2021-05-29 02:15 2021-05-28 D'Amico Alex Officer - Chief Financial Officer BUY $38.00 660 $25,077 2,160 +44.0%
2021-05-20 04:44 2021-05-17 Thronson Susan Director BUY $40.30 1,175 $47,347 5,772 +25.6%
SHOW ENTRIES

How to Interpret $TRUL Trades

Not every insider transaction in Trulieve Cannabis Corp. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $TRUL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for TRUL

Insider activity data for Trulieve Cannabis Corp. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $TRUL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.